Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [online].Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed 12 May 2021.
2. Bowring J, Strander B, Young M, et al. The Swede score: evaluation of a scoring system designed to improve the predictive value of colposcopy. Am Soc Colposc Cerv Pathol J Lower Genit Tract Dis. 2010;14:301–5.
3. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579–88.
4. Madeddu G, Mameli G, Capobianco G, et al. HPV infection in HIV- positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. Eur Rev Med Pharmacol Sci. 2014;18:1277–85.
5. Bornstein J, Bentley J, Bosze P, et al. 2011 colposcopic terminology of the international federation for cervical pathology and colposcopy. Obstet Gynecol. 2012;120(1):166–72.